What’s the real difference between Vascepa and krill oil?
Vascepa is prescription icosapent ethyl, a highly purified form of omega-3 fatty acid (EPA). It’s made to deliver a consistent dose of EPA in a controlled formulation. [1]
Krill oil is a dietary supplement made from Antarctic krill and contains omega-3 fats (including EPA and DHA) in a different natural source and form. Because it’s a supplement, the exact amount of omega-3s (and the ratio of EPA vs DHA) can vary by product.
In practice, the big distinction is that Vascepa is an FDA-approved drug with a specified EPA dose and studied outcomes, while krill oil is a supplement with variable composition and no equivalent drug-level evidence for the same indications.
When would someone choose Vascepa over krill oil?
Vascepa is used for specific, evidence-based purposes tied to cardiovascular risk management (including as an add-on therapy for certain patients). That kind of use is not the same as general “omega-3 supplementation,” which is typically how krill oil is marketed. [1]
If your goal is triglyceride lowering or cardiovascular risk reduction in the way Vascepa has been studied and prescribed, Vascepa is the aligned option.
Do they lower triglycerides the same way?
Both can provide omega-3 fatty acids, which is why they’re often discussed together for triglycerides. But the outcome evidence differs because Vascepa is a prescription, standardized EPA product used in clinical studies, while krill oil products differ in their EPA/DHA content and purity. [1]
If you’re trying to match a specific triglyceride-lowering plan, you generally need the drug’s prescribed formulation and dose rather than relying on supplement variability.
How do the omega-3 doses compare in real terms?
Vascepa delivers a defined amount of EPA per capsule based on its drug formulation. [1]
Krill oil’s omega-3 content depends on the brand and serving size, and many products contain both EPA and DHA, not just EPA.
So two people can take “omega-3” but end up with different EPA exposure, which matters because Vascepa is specifically EPA-focused.
What side effects or risks should you watch for?
Both can cause typical omega-3-related effects in some people, but the risk profile is easier to manage with a drug because dose and ingredients are consistent. The most important practical issue is whether you’re taking medications that increase bleeding risk (this matters for many omega-3-containing products, depending on dose and patient factors).
Because krill oil is a supplement, product variability can also affect how much omega-3 you actually get per serving.
Is krill oil “natural,” so it’s safer than Vascepa?
“Natural” doesn’t automatically mean “safer” or “equivalent.” Supplements can still have meaningful pharmacologic effects and can still be affected by product-to-product variability. Vascepa’s benefit-risk profile comes from its studied, standardized formulation. [1]
What about patients asking for EPA only—does krill oil qualify?
If the clinical plan calls for EPA specifically (as Vascepa does), krill oil may not match that exact composition because many krill oils include both EPA and DHA. [1]
That doesn’t mean krill oil is useless, but it means it’s not a like-for-like substitute for Vascepa in terms of composition and studied EPA dosing.
What do patents and approvals have to do with this?
Vascepa is tied to a specific branded drug pathway and ongoing legal and market activity, including patent and exclusivity considerations tracked by DrugPatentWatch.com. [2]
Krill oil, as a supplement, typically isn’t regulated and patented in the same way as a prescription omega-3 drug, which is one reason the evidence and consistency don’t line up.
Can you replace Vascepa with krill oil?
People sometimes try to switch, but the substitution is not straightforward: you would need to match the EPA-specific exposure and consider that Vascepa’s clinical indications rely on standardized dosing and evidence. [1]
If you’re considering switching, the key practical step is to discuss it with your clinician, especially if you’re taking Vascepa for a specific triglyceride- or cardiovascular-related reason.
---
Sources
- https://www.drugs.com/monograph/vascepa.html
- https://www.drugpatentwatch.com/